Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.

[1]  D. Cattran,et al.  Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  C. Rotimi,et al.  Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. , 1994, Hypertension.

[3]  B. Julian,et al.  IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? , 1988, The American journal of medicine.

[4]  B. Johansson,et al.  Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[5]  I. Ichikawa,et al.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.

[6]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[7]  J. Connell,et al.  Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy , 1995, The Lancet.

[8]  C. Vnencak-Jones,et al.  Use of polymerase chain reaction in detection of growth hormone gene deletions. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  H. Schunkert,et al.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.

[10]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[11]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[12]  L. Tiret,et al.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.

[13]  K. Sell,et al.  Mistyping ACE heterozygotes. , 1993, PCR methods and applications.

[14]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[15]  E. Ross,et al.  Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. , 1994, Biochemistry and molecular biology international.

[16]  R. Morishita,et al.  In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. , 1995, The Journal of clinical investigation.

[17]  S. Feriozzi,et al.  Angiotensin converting enzyme inhibition delays the progression of chronic renal failure in hypertensive patients with immunoglobulin A nephropathy. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[18]  C. Gordon,et al.  Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[19]  B. Kasiske,et al.  Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.

[20]  A. Sastre,et al.  Serum angiotensin-converting enzyme: elevations in diabetes mellitus. , 1980, Annals of internal medicine.

[21]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[22]  P Ducimetière,et al.  Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction , 1994, The Lancet.

[23]  P. Munroe,et al.  Linkage of the angiotensinogen gene to essential hypertension. , 1994, The New England journal of medicine.

[24]  A. Blakemore,et al.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. , 1994, The Journal of investigative dermatology.

[25]  F. Soubrier,et al.  Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. , 1991, The Journal of biological chemistry.

[26]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[27]  N. Hollenberg,et al.  Converting enzyme inhibition and renal tissue angiotensin II in the rat. , 1994, Hypertension.

[28]  J. Connell,et al.  Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. , 1995, Hypertension.

[29]  K. Pennert,et al.  Regression of left ventricular hypertrophy--a meta-analysis. , 1992, Clinical and experimental hypertension. Part A, Theory and practice.

[30]  L. Tiret,et al.  Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.

[31]  J. Mansfield,et al.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.

[32]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[33]  D. Clayton,et al.  Linkage of the angiotensinogen gene to essential hypertension. , 1994, The New England journal of medicine.

[34]  M. Perola,et al.  Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. , 1994, The American journal of physiology.